SCHEMBL4674490

SCHEMBL4674490

O=C(C=C(O)c1nn[nH]n1)c1cnn(Cc2ccccc2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 4/20 0.43
RIPK1 Q13546 1/20 0.41
CES1 P23141 1/20 0.40
NCEH1 Q6PIU2 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
POLB P06746 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ITK Q08881 1/20 0.39
PSD A5PKW4 1/20 0.39
NAMPT P43490 2/20 0.39
SCD5 Q86SK9 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CREBBP Q92793 1/20 0.37
CDC7 O00311 1/20 0.37
PTGS1 P23219 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
NCOR2 Q9Y618 1/20 0.37
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4676019 0.91 KLKB1 (0.40) KLKB1RIPK1HSD17B10ALDH1A1
SCHEMBL4673744 0.91 KLKB1 (0.38) KLKB1RIPK1CES1NCEH1L3MBTL1
SCHEMBL4671607 0.90 LMNA (0.43) KLKB1HSD17B10CREBBPHDAC3HDAC8
SCHEMBL4676023 0.90 KLKB1 (0.42) KLKB1POLBHSD17B10ALDH1A1
SCHEMBL4674633 0.89 HSD17B10 (0.40) KLKB1HSD17B10ALDH1A1
SCHEMBL4672655 0.89 KLKB1 (0.43) KLKB1L3MBTL1POLBTDP1SCD5
SCHEMBL4674679 0.88 L3MBTL1 (0.44) KLKB1L3MBTL1HSD17B10ERCC5FEN1
SCHEMBL4672787 0.86 CREBBP (0.41) CES1NCEH1L3MBTL1CREBBPHDAC3
SCHEMBL4670984 0.86 ALDH1A1 (0.46) KLKB1L3MBTL1SCD5ALDH1A1ERCC5
SCHEMBL4678760 0.82 KLKB1 (0.41) KLKB1RIPK1L3MBTL1POLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142872-B1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO (JP) 2008-10-15 EP disclosed
US-7098201-B2 Heteroaromatic derivatives having an inhibitory activity against HIV integrase SHIONOGI & CO., LTD. (JP) 2006-08-29 US disclosed
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase FUJISHITA TOSHIO (JP) 2004-01-01 US disclosed
US-6645956-B1 1-(5-(4-fluorobenzyl)furan-2-yl)-3-hydroxy-3-(1H-1,2,4-triazol-3 -yl)-propenone; viricides; AIDS treatment SHIONOGI & CO., LTD. (JP) 2003-11-11 US disclosed
US-6620841-B1 Furan or benzofuran derivatives substituted with triazole; acquired immunodeficiency syndrome (AIDS) SHIONOGI & CO., LTD. (JP) 2003-09-16 US disclosed
CN-1335834-A Aromatic heterocyclic compounds having HIV integrase inhibitory activity SHIONOGI & CO (JP) 2002-02-13 CN disclosed
EP-1142872-A1 AROMATIC HETEROCYCLE COMPOUNDS HAVING HIV INTEGRASE INHIBITING ACTIVITIES SHIONOGI & CO., LTD. (JP) 2001-10-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040002485-A1 Heteroaromatic derivatives having an inhibitory activity against HIV integrase RCOR1, BCOR, CYP8B1 KLKB1 3843/4885RIPK1 4278/4885CES1 445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.